Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser, Richard Molenkamp, Adam Meijer, Daniel K. W. Chu, Tobias Bleicker, Sebastian Brünink, Julia A. Schneider, Marie Luisa Schmidt, Daphne G.J.C. Mulders, Bart L. Haagmans, Bas van der Veer, Sharon van den Brink, Lisa A. Wijsman, Gabriel Goderski, Jean‐Louis Romette, Joanna Ellis, Maria Cristina Fleischmann Alves Zambon, Malik J. S. Peiris, Herman Goossens, Chantal B. E. M. Reusken, Marion Koopmans, Christian Drosten
Eurosurveillance · 2020 · 7,448 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K. W., Bleicker, T., Brünink, S., Schneider, J. A., Schmidt, M. L., Mulders, D. G., Haagmans, B. L., Veer, B. van der, Brink, S. van den, Wijsman, L. A., Goderski, G., Romette, J., Ellis, J., Zambon, M. C. F. A., … Drosten, C. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3). https://doi.org/10.2807/1560-7917.es.2020.25.3.2000045
In text: (Corman et al., 2020)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. AIM: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. METHODS: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. RESULTS: The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project. CONCLUSION: The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
Related papers
- Clinical Characteristics of Coronavirus Disease 2019 in China2020
- A Novel Coronavirus from Patients with Pneumonia in China, 20192020
- A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020
Metadata from OpenAlex (CC0). Citations are generated from the published record.